Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Invested Capital (2016 - 2025)

Historic Invested Capital for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to $273.3 million.

  • Ascendis Pharma A's Invested Capital rose 4781.38% to $273.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $853.0 million, marking a year-over-year increase of 2691.13%. This contributed to the annual value of $812.7 million for FY2024, which is 5150.9% up from last year.
  • As of Q3 2025, Ascendis Pharma A's Invested Capital stood at $273.3 million, which was up 4781.38% from $211.2 million recorded in Q2 2025.
  • Ascendis Pharma A's 5-year Invested Capital high stood at $1.2 billion for Q3 2021, and its period low was $94.1 million during Q2 2023.
  • For the 5-year period, Ascendis Pharma A's Invested Capital averaged around $528.7 million, with its median value being $536.4 million (2023).
  • Per our database at Business Quant, Ascendis Pharma A's Invested Capital crashed by 8758.15% in 2023 and then soared by 8209.27% in 2024.
  • Ascendis Pharma A's Invested Capital (Quarter) stood at $1.1 billion in 2021, then tumbled by 30.38% to $787.4 million in 2022, then crashed by 31.87% to $536.4 million in 2023, then soared by 49.59% to $802.4 million in 2024, then tumbled by 65.94% to $273.3 million in 2025.
  • Its Invested Capital was $273.3 million in Q3 2025, compared to $211.2 million in Q2 2025 and $183.6 million in Q1 2025.